From Wikipedia, the free encyclopedia
(Redirected from HSD17B5)
AKR1C3
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
Aliases AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS, aldo-keto reductase family 1, member C3, aldo-keto reductase family 1 member C3
External IDs OMIM: 603966; MGI: 2145420; HomoloGene: 128661; GeneCards: AKR1C3; OMA: AKR1C3 - orthologs
EC number 1.3.1.20
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_003739
NM_001253908
NM_001253909
NM_016253

NM_134066
NM_001346535

RefSeq (protein)

NP_001240837
NP_001240838
NP_003730

NP_001333464
NP_598827

Location (UCSC) Chr 10: 5.04 – 5.11 Mb Chr 13: 4.18 – 4.2 Mb
PubMed search [3] [4]
Wikidata
View/Edit Human View/Edit Mouse

Aldo-keto reductase family 1 member C3 (AKR1C3), also known as 17β-hydroxysteroid dehydrogenase type 5 (17β-HSD5, HSD17B5) or 3α-hydroxysteroid dehydrogenase type 2 (3α-HSD2) [5] [6] [7] is a steroidogenic enzyme that in humans is encoded by the AKR1C3 gene. [8] [9] [10]

Function

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin D2, prostaglandin H2, and phenanthrenequinone, and the oxidation of prostaglandin F to prostaglandin D2. [10] It is also capable of metabolizing estrogen and progesterone. [11]

AKR1C3 may play an important role in the development of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. [10]

Pathology

AKR1C3 is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). In addition, AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression. [12]

Isozymes of aldo-keto reductase family 1 member C

HGNC Gene Symbol Enzyme Name Aliases [13]
AKR1C1 aldo-keto reductase family 1 member C1; 20α-hydroxysteroid dehydrogenase
AKR1C2 aldo-keto reductase family 1 member C2; 3α-hydroxysteroid dehydrogenase type 3
AKR1C3 aldo-keto reductase family 1 member C3; 3α-hydroxysteroid dehydrogenase type 2; 17β-hydroxysteroid dehydrogenase type 5; HSD17B5
AKR1C4 aldo-keto reductase family 1 member C4; 3α-hydroxysteroid dehydrogenase type 1

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000196139Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021214Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Zhang B, Zhu DW, Hu XJ, Zhou M, Shang P, Lin SX (May 2014). "Human 3-alpha hydroxysteroid dehydrogenase type 3 (3α-HSD3): The V54L mutation restricting the steroid alternative binding and enhancing the 20α-HSD activity". The Journal of Steroid Biochemistry and Molecular Biology. 141: 135–143. doi: 10.1016/j.jsbmb.2014.01.003. PMID  24434280.
  6. ^ Li T, Zhang W, Lin SX (February 2020). "Steroid enzyme and receptor expression and regulations in breast tumor samples – A statistical evaluation of public data". The Journal of Steroid Biochemistry and Molecular Biology. 196: 105494. doi: 10.1016/j.jsbmb.2019.105494. PMID  31610224.
  7. ^ Masiutin MM, Yadav MK (3 April 2023). "Alternative androgen pathways" (PDF). WikiJournal of Medicine. 10: 29. doi: 10.15347/WJM/2023.003. S2CID  257943362.  This article incorporates text from this source, which is available under the CC BY 4.0 license.
  8. ^ Khanna M, Qin KN, Wang RW, Cheng KC (August 1995). "Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases". Journal of Biological Chemistry. 270 (34): 20162–20168. doi: 10.1074/jbc.270.34.20162. PMID  7650035.
  9. ^ Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S (November 1998). "Identification of a Principal mRNA Species for Human 3 -Hydroxysteroid Dehydrogenase Isoform (AKR1C3) That Exhibits High Prostaglandin D2 11-Ketoreductase Activity". Journal of Biochemistry. 124 (5): 940–946. doi: 10.1093/oxfordjournals.jbchem.a022211. PMID  9792917.
  10. ^ a b c EntrezGene 8644 AKR1C3 aldo-keto reductase family 1 member C3 [ Homo sapiens (human) ]
  11. ^ Theisen JG, Sundaram V, Filchak MS, Chorich LP, Sullivan ME, Knight J, Kim HG, Layman LC (27 December 2019). "The Use of Whole Exome Sequencing in a Cohort of Transgender Individuals to Identify Rare Genetic Variants". Scientific Reports. 9 (1). Table 4. Bibcode: 2019NatSR...920099T. doi: 10.1038/s41598-019-53500-y. PMC  6934803. PMID  31882810.
  12. ^ Tian Y, Zhao L, Zhang H, Liu X, Zhao L, Zhao X, Li Y, Li J (December 2014). "AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression". Diagnostic Pathology. 9 (1): 42. doi: 10.1186/1746-1596-9-42. PMC  3939640. PMID  24571686.
  13. ^ Dufort I, Labrie F, Luu-The V (February 2001). "Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases: differential lability and tissue distribution". J Clin Endocrinol Metab. 86 (2): 841–6. doi: 10.1210/jcem.86.2.7216. PMID  11158055. human types 1 and 3 3α-HSD, 20α-HSD, and type 5 17β-HSD were named AKR1C4, AKR1C2, AKR1C1, and AKR1C3, respectively

External links

Further reading